SCHEMBL439655

SCHEMBL439655

CCOc1ccc2nc(C)cc(N)c2c1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.80
▸ HSD17B10 Q99714 3/20 0.80
▸ CASP1 P29466 1/20 0.80
▸ CASP7 P55210 1/20 0.80
▸ SMN1; SMN2 Q16637 3/20 0.63
▸ TSHR P16473 2/20 0.63
▸ CYP1A2 P05177 2/20 0.63
▸ KDM4E B2RXH2 1/20 0.63
▸ HPGD P15428 1/20 0.63
▸ KMT2A Q03164 3/20 0.56
▸ MEN1 O00255 2/20 0.56
▸ BLM P54132 2/20 0.56
▸ TERT O14746 2/20 0.56
▸ LMNA P02545 2/20 0.56
▸ ABCB11 O95342 1/20 0.56
▸ THRB P10828 1/20 0.56
▸ TP53 P04637 2/20 0.55
▸ SLC2A1 P11166 1/20 0.55
▸ NCF1 P14598 1/20 0.51
▸ CYP3A4 P08684 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3471999 0.89 ALDH1A1 (1.00) ALDH1A1HSD17B10CASP1CASP7SMN1; SMN2
SCHEMBL19983503 0.84 ALDH1A1 (0.67) ALDH1A1HSD17B10CASP1CASP7SMN1; SMN2
SCHEMBL437286 0.82 HSD17B10 (0.71) ALDH1A1HSD17B10CASP1CASP7SMN1; SMN2
SCHEMBL21173411 0.81 ALDH1A1 (0.68) ALDH1A1HSD17B10CASP1CASP7SMN1; SMN2
SCHEMBL10901432 0.81 ALDH1A1 (0.68) ALDH1A1HSD17B10CASP1CASP7SMN1; SMN2
SCHEMBL10899393 0.80 SMN1; SMN2 (0.62) ALDH1A1HSD17B10CASP1CASP7SMN1; SMN2
SCHEMBL21173382 0.80 ALDH1A1 (0.62) ALDH1A1HSD17B10CASP1CASP7SMN1; SMN2
SCHEMBL4748820 0.78 ALDH1A1 (0.66) ALDH1A1HSD17B10CASP1CASP7SMN1; SMN2
SCHEMBL27906713 0.78 ALDH1A1 (0.65) ALDH1A1HSD17B10CASP1CASP7SMN1; SMN2
SCHEMBL10251292 0.78 NR4A2 (0.53) ALDH1A1HSD17B10CASP1CASP7SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022093871-A1 SARS-C0V-2 INACTIVATION BY ETHACRIDINE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-05-05 — — WO disclosed
US-20120065166-A1 Bone Modulators And Methods Therewith ESPINA VIRGINIA (US) 2012-03-15 — — US disclosed
Send feedback